// App-Quantinova.ai

: Characterization of the NIA-AA Research Framework stage 2 in the longitudinal multicenter DELCODE study

Researchers

Presenter

  • Lena Sannemann

Principal Investigators

  • Dix U. Meiberth

  • Ann-Katrin Schild

  • Katharina Bürger

  • Michael T. Heneka

  • Christoph Laske

  • Robert Perneczky

  • Oliver Peters

  • Josef Priller

  • Anja Schneider

  • Annika Spottke

  • Stefan Teipel

  • Michael Wagner

  • Jens Wiltfang

  • Steffen Wolfsgruber

  • Emrah Duzel

  • Frank Jessen

Medical Centers

  • Institute for Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University

  • German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany

  • German Center for Neurodegenarative Diseases (DZNE)

  • Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro

  • Munich Cluster for Systems Neurology (SyNergy)

  • Department of Psychiatry, University of Cologne, Medical Faculty, Kerpener Strasse 62

  • Imperial College, London, UK

  • Department of Psychiatry and Psychotherapy, University Medical Center, University of Goettingen

  • Department of Psychosomatic Medicine, Rostock University Medical Center

  • Department of Neurology, University of Pennsylvania

  • Department of Psychiatry, Charité – Universitätsmedizin Berlin

  • Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany

  • Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen

  • Institute for Stroke and Dementia Research

  • Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich

  • University of Cologne, Faculty of Medicine and University Hospital Cologne

Locations

  • Germany

  • Portugal

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

  • Dementia

Biomarkers

  • Stearoyl-CoA desaturase

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A